Melittin-loaded immunoliposomes against viral surface proteins, a new approach to antiviral therapy

Antiviral Research

Volumn 97, Issue 2, 2013, Pages 218-221

  Falco, Alberto ^a   Barrajón Catalán, Enrique ^a   Menéndez Gutiérrez, María P ^a   Coll, Julio ^b   Micol, Vicente ^a   Estepa, Amparo ^a  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b INIA   (Spain)

Author keywords

Antiviral therapy; G glycoprotein; Immunoliposomes; Melittin; VHSV

Indexed keywords

GLYCOPROTEIN; IMMUNOLIPOSOME; MELITTIN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ANTIVIRAL THERAPY; ARTICLE; CELL CULTURE; CELL MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FISH DISEASE; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; VIRAL HEMORRHAGIC SEPTICEMIA VIRUS; VIRUS INACTIVATION; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; FISHES; LIPOSOMES; MELITTEN; MEMBRANE PROTEINS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; NOVIRHABDOVIRUS; VIRAL PROTEINS; VIRUS INACTIVATION;

EID: 84873192636     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2012.12.004     Document Type: Article

References (20)

1. Lai Y., Gallo R.L. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 2009, 30:131-141.
2. Ganz T. Antimicrobial proteins and peptides in host defense. Semin. Respir. Infect. 2001, 16:4-10.
3. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415:389-395.
4. Patrzykat A., Douglas S.E. Antimicrobial peptides: cooperative approaches to protection. Protein Pept. Lett. 2005, 12:19-25.
5. Jelinek R., Kolusheva S. Membrane interactions of host-defense peptides studied in model systems. Curr. Protein Pept. Sci. 2005, 6:103-114.
6. Shai Y. Mode of action of membrane active antimicrobial peptides. Biopolymers 2002, 66:236-248.
7. Hancock R.E., Scott M.G. The role of antimicrobial peptides in animal defenses. Proc. Natl. Acad. Sci. U S A 2000, 97:8856-8861.
8. Noble C.O., Kirpotin D.B., Hayes M.E., Mamot C., Hong K., Park J.W., Benz C.C., Marks J.D., Drummond D.C. Development of ligand-targeted liposomes for cancer therapy. Expert Opin. Ther. Targets 2004, 8:335-353.
9. Park J.W., Hong K., Kirpotin D.B., Papahadjopoulos D., Benz C.C. Immunoliposomes for cancer treatment. Adv. Pharmacol. 1997, 40:399-435.
10. Barrajon-Catalan E., Menendez-Gutierrez M.P., Falco A., Carrato A., Saceda M., Micol V. Selective death of human breast cancer cells by lytic immunoliposomes: correlation with their HER2 expression level. Cancer Lett. 2010, 290:192-203.
11. Barrajón-Catalán, E, Menéndez-Gutiérrez, M.P., Falco, A., Saceda, M., Catania, A., Micol, V., 2011. Immunoliposomes: a multipurpose strategy in breast cancer targeted therapy. In: Esra Gunduz and Mehmet Gunduz (Eds.), In Breast Cancer - Current and Alternative Therapeutic Modalities. InTech, pp. 435-452.
12. Lorenzen N., LaPatra S.E. DNA vaccines for aquacultured fish. Rev. Sci. Technol. 2005, 24:201-213.
13. Estepa A., Coll J.M. Pepscan mapping and fusion-related properties of the major phosphatidylserine-binding domain of the glycoprotein of viral hemorrhagic septicemia virus, a salmonid rhabdovirus. Virology 1996, 216:60-70.
14. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
15. Lorenzo G., Estepa A., Coll J.M. Fast neutralization/immunoperoxidase assay for viral haemorrhagic septicaemia with anti-nucleoprotein monoclonal antibody. J. Virol. Methods 1996, 58:1-6.
16. LeBerre M., De Kinkelin P., Metzger A. Identification sérologique des rhabdovirus des salmonidés. Bull. Off. Int. Epizoot. 1997, 87:391-393.
17. Clayton R., Ohagen A., Nicol F., Del Vecchio A.M., Jonckers T.H., Goethals O., Van Loock M., Michiels L., Grigsby J., Xu Z., Zhang Y.P., Gutshall L.L., Cunningham M., Jiang H., Bola S., Sarisky R.T., Hertogs K. Sustained and specific in vitro inhibition of HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomes. Antiviral Res. 2009, 84:142-149.
18. Gagne J.F., Desormeaux A., Perron S., Tremblay M.J., Bergeron M.G. Targeted delivery of indinavir to HIV-1 primary reservoirs with immunoliposomes. Biochim. Biophys. Acta 2002, 1558:198-210.
19. Selvam M.P., Buck S.M., Blay R.A., Mayner R.E., Mied P.A., Epstein J.S. Inhibition of HIV replication by immunoliposomal antisense oligonucleotide. Antiviral Res. 1996, 33:11-20.
20. Falco A., Mas V., Tafalla C., Perez L., Coll J.M., Estepa A. Dual antiviral activity of human alpha-defensin-1 against viral haemorrhagic septicaemia rhabdovirus (VHSV): inactivation of virus particles and induction of a type I interferon-related response. Antiviral Res. 2007, 76:111-123.